Understanding how a specific protein complex modifies genes related to mental health and cancer.
Structure and Mechanism of the SET1/COMPASS H3K4 Methyltransferase Complex
This study is looking at a special protein complex that helps control how our genes work, which could give us important clues about mental health issues like autism and schizophrenia, as well as some cancers, to help improve understanding and treatment for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10906012 on NIH RePORTER |
What this research studies
This research investigates the SET1/COMPASS protein complex, which plays a crucial role in modifying histones, a type of protein that helps package DNA in cells. By studying this complex, researchers aim to uncover how it influences gene expression, particularly in relation to mental health conditions like autism and schizophrenia, as well as certain cancers. The approach involves using advanced biochemical techniques and model organisms to analyze the structure and function of these proteins. Patients may benefit from insights gained about the genetic factors contributing to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autism, schizophrenia, or related mental health disorders, as well as those affected by specific cancers.
Not a fit: Patients with conditions unrelated to the SET1/MLL methyltransferases or those not diagnosed with the mentioned disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for mental health disorders and certain cancers linked to the SET1/MLL methyltransferases.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar protein complexes in gene regulation and their implications for various diseases.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Zheng, Ning — University of Washington
- Study coordinator: Zheng, Ning
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.